Proteomics International Laboratories has inked an expanded research deal with the University of Melbourne and Royal Women’s Hospital to pinpoint its attack on early endometriosis identification.

Proteomics International Laboratories has achieved certification for its Perth lab, which will provide world-class test results for...

Trials of Proteomics International’s PromarkerEso blood test have delivered a near-perfect score for the detection of throat cancer...

Proteomics International Laboratories’ innovative OxiDx muscle stress test could soon be used to monitor muscle damage in thoroughbred...

Proteomics International’s PromarkerD diabetes-related blood test has just been assigned an American Medical Association billing code,...

Proteomics research scientist Martin Mead adjusts a mass spectrometer column used for its proteomics diagnostics research in the...

Proteomics International has patented PromarkerEndo, its breakthrough early diagnostic test for endometriosis, in Japan. In a milestone...

Proteomics International Laboratories has officially launched the US rollout of its PromarkerD kidney diagnostic test at a conference in...

Newly published results from Proteomics International have revealed its PromarkerEso blood test can detect early oesophageal cancer with...

Proteomics International groundbreaking, simple endometriosis blood test could revolutionise healthcare for the disease. ASX-listed...

A majority owned subsidiary of Proteomics International has picked up a Chinese patent for a finger-prick test that tracks oxidative muscle stress linked to most sports and horse racing injuries.

Proteomics International Laboratories managing director Dr Richard Lipscombe. The company has locked in $4.5 million to fast-track the...

Proteomics International Laboratories ls launching its PromarkerEso esophageal cancer test globally, backed by a top-tier clinical board...

A Proteomics International Laboratories subsidiary has received an Australian patent for its finger-prick blood test that tracks muscle...

Assay plates on an automated platform using PromarkerD to test for the early signs of chronic kidney disease in type 2 diabetes patients....

Results from a trial of Proteomics International Laboratories’ PromarkerD blood test for the detection of chronic kidney disease have...

Proteomics International Laboratories has opened a new laboratory in the United States, certified by the State of California, to roll out...

OxiDx, a majority-owned subsidiary of biotech company Proteomics International, has revealed a simple fingerprick test to detect and...

Proteomics International’s game-changing PromarkerEndo diagnostic blood test for endometriosis has passed its latest clinical trials with...

Perth-based Proteomics International has received a $2.16m R&D for costs incurred in the previous financial year on the research of...